卵巢癌组织中uPA与PAI1 mRNA表达及意义(4)

2025-08-23

［5］孙显路，孙仁寿，李玉军. 尿激酶型纤溶酶原激活物及其受体表达与胰腺癌浸润和转移的关系［J］. 青岛大学医学院学报, 2003,39(3):244245.

［6］毛昕,李延江. uPA 与uPAR 在肾细胞癌中的表达及其意义［J］. 齐鲁医学杂志, 2003,18(2):121122.

［7］KONECNY G, UNTCH M， PIHAN A， et al. Association of urokinasetype plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer［J］. Clin Cancer Res, 2001,7:17431749.

［8］ISOGAI C， LAUG W E， SHIMADA H， et al. Plasminogen activator inhibitor1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin［J］. Cancer Res, 2002,61(14):55875594.

［9］TECIMER C, DOERING D L, GOLDSMITH L J， et al. Clinical revelence of urokinasetype plasminogen activator, its receptor and inhibitor type1 in ovarion cancer［J］. Int J Gynecol Cancer, 2000,10(5):372381.

共4页:

卵巢癌组织中uPA与PAI1 mRNA表达及意义(4).doc 将本文的Word文档下载到电脑下载失败或者文档不完整，请联系客服人员解决！

下载这篇word文档